Delivery Order SPE2DB22D3501-SPE2DB24FWJ64

Award Date 7/23/24
Potential Completion Date 8/13/24
Potential Value $8.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,593.77 firm fixed-price contract is for the supply of CALQUENCE 100 MG TABLET 60S, a pharmaceutical product. The award has an ultimate completion date of February 21, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of CALQUENCE 100 MG TABLET 60S medication. The $8,575.36 firm-fixed-price contract has a completion date of November 19, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a global pharmaceutical sourcing and distribution company. The $8,575.36 contract is for the delivery of CALQUENCE 100 MG TABLET 60S, a specialty pharmaceutical product, to support military treatment programs and facilities. The delivery order was issued under a larger, single-award indefinite delivery...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The $8,575.36 award is for the supply of CALQUENCE 100 MG TABLET 60S, a pharmaceutical product, with a completion date of February 20, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CALQUENCE 100 MG TABLET 60S, a pharmaceutical product, with a firm fixed price of $11,187.56 and a completion date of June 17, 2025. The contract is not set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a $25,726.08 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract provides for the delivery of CALQUENCE 100 MG TABLET 60S, a pharmaceutical product, with an ultimate completion date of October 7, 2024. This order is a part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a comprehensive...
This is a $8,575.36 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of CALQUENCE 100 MG TABLET 60S, a specialty pharmaceutical product. The order has a completion date of May 30, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which provides a...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 60 tablets of the pharmaceutical product CALQUENCE 100 MG for $8,575.36. This delivery order has a completion date of March 11, 2024 and was awarded on February 16, 2024. The award is not set-aside and is part of a larger indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp with DLA, with a potential value of up...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $8,575.36 Firm Fixed Price Delivery Order is for the supply of 4565519523 CALQUENCE 100 MG TABLET 60S, a specialty medication. The contract has an ultimate completion date of September 11, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The award, valued at $8,575.36, is for the supply of CALQUENCE 100 MG TABLET 60S, a specialty pharmaceutical product. The contract has a period of performance through March 6, 2024 and does not include any set-aside designation. Amerisourcebergen Drug Corp holds an indefinite...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB24FWJ64
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 100 mg CALQUENCE tablets. The $8,575.36 firm fixed-price contract has an ultimate completion date of August 13, 2024. It is not set aside for any specific business type. This award is likely part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at up to $999,999,999, which enables the DLA to efficiently procure a wide range of medical commodities, including prescription drugs and supplies, to support military treatment programs and facilities worldwide.

Generated 10/22/24, 9:22 AM